178 related articles for article (PubMed ID: 30061623)
1. The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion.
Padilla-Rodriguez M; Parker SS; Adams DG; Westerling T; Puleo JI; Watson AW; Hill SM; Noon M; Gaudin R; Aaron J; Tong D; Roe DJ; Knudsen B; Mouneimne G
Nat Commun; 2018 Jul; 9(1):2980. PubMed ID: 30061623
[TBL] [Abstract][Full Text] [Related]
2. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
Giretti MS; Fu XD; De Rosa G; Sarotto I; Baldacci C; Garibaldi S; Mannella P; Biglia N; Sismondi P; Genazzani AR; Simoncini T
PLoS One; 2008 May; 3(5):e2238. PubMed ID: 18493596
[TBL] [Abstract][Full Text] [Related]
3. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion.
Mouneimne G; Hansen SD; Selfors LM; Petrak L; Hickey MM; Gallegos LL; Simpson KJ; Lim J; Gertler FB; Hartwig JH; Mullins RD; Brugge JS
Cancer Cell; 2012 Nov; 22(5):615-30. PubMed ID: 23153535
[TBL] [Abstract][Full Text] [Related]
4. Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells.
Shortrede JE; Uzair ID; Neira FJ; Flamini MI; Sanchez AM
Mol Cell Endocrinol; 2016 Jul; 430():56-67. PubMed ID: 27095481
[TBL] [Abstract][Full Text] [Related]
5. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
6. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
[TBL] [Abstract][Full Text] [Related]
7. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.
McDermott MS; Chumanevich AA; Lim CU; Liang J; Chen M; Altilia S; Oliver D; Rae JM; Shtutman M; Kiaris H; Győrffy B; Roninson IB; Broude EV
Oncotarget; 2017 Feb; 8(8):12558-12575. PubMed ID: 28147342
[TBL] [Abstract][Full Text] [Related]
9. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
11. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
Azios NG; Krishnamoorthy L; Harris M; Cubano LA; Cammer M; Dharmawardhane SF
Neoplasia; 2007 Feb; 9(2):147-58. PubMed ID: 17356711
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway.
Goto N; Hiyoshi H; Ito I; Tsuchiya M; Nakajima Y; Yanagisawa J
Cancer Sci; 2011 Aug; 102(8):1501-8. PubMed ID: 21564419
[TBL] [Abstract][Full Text] [Related]
14. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
15. Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer.
Thomas C; Karagounis IV; Srivastava RK; Vrettos N; Nikolos F; Francois N; Huang M; Gong S; Long Q; Kumar S; Koumenis C; Krishnamurthy S; Ueno NT; Chakrabarti R; Maity A
Cancer Res; 2021 May; 81(9):2399-2414. PubMed ID: 33514514
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
18. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
[TBL] [Abstract][Full Text] [Related]
19. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
[TBL] [Abstract][Full Text] [Related]
20. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
